Faron Pharmaceuticals - Innovatiivisia lääketieteen ratkaisuja (Osa 2)

Unfortunately, science has no value until supply and demand meet. How and when this deal happens then sets a baseline value for the company. Of course, its scientific and other development, as well as the market, then further determine the direction of value development. I understand that Faron and its results must be promoted, but even yesterday’s aforementioned smoke (without a mirror), as well as previous management speeches and HCM, constantly add to the burden – unfortunately.
And Gubrik is right about that – that unless there is commercial news soon (within 3 months) – Faron is in a death spiral.
Hopefully, someone gets to hear JJ’s stories today at that campfire. Probably the last “bedtime story” for this year, so the entire forum is indeed awaiting information and impressions from that presentation.
Of course, as long as there’s time, GoFaronGo

6 Likes